Regulatory Affairs Syndicator

Newsday - Risperdal, an anti-psychotic drug, has just been approved by the Food and Drug Administration to treat the symptoms of autism in children and adolescents ages 5 to 16. It’s the first time the FDA has approved any drug to treat behaviors such as …

Newsday - Risperdal, an anti-psychotic drug, has just been approved by the Food and Drug Administration to treat the symptoms of autism in children and adolescents ages 5 to 16. It’s the first time the FDA has approved any drug to treat behaviors such as …

Fort Lauderdale Sun-Sentinel - Risperdal, an anti-psychotic drug, has just been approved by the Food and Drug Administration to treat the symptoms of autism in children and adolescents ages 5 to 16. It’s the first time the FDA has approved any drug to treat behaviors such as …

Newsday - Risperdal, an anti-psychotic drug, has just been approved by the Food and Drug Administration to treat the symptoms of autism in children and adolescents ages 5 to 16. It’s the first time the FDA has approved any drug to treat behaviors such as …

Newsday - Risperdal, an anti-psychotic drug, has just been approved by the Food and Drug Administration to treat the symptoms of autism in children and adolescents ages 5 to 16. It’s the first time the FDA has approved any drug to treat behaviors such as …